Cabaletta Bio, Inc. · NASDAQ:CABA
T. Rowe Price Investment Management, Inc. reported a 10.20% stake in Cabaletta Bio, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
T. Rowe Price Investment Management, Inc. reported a 10.20% stake in Cabaletta Bio, Inc., 9,858,257 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 10.20%
- Shares
- 9,858,257
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10.20% | 9,858,257 |
Source
Related
- Cabaletta Bio, Inc.
- T. Rowe Price Investment Management, Inc.
- Cabaletta Bio, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 7, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 7, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Norges Bank · Aug 12, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026